Nucleic Acid Nanoparticles for Genetic Cargo Delivery

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current therapeutic and diagnostic procedures face challenges in efficiently delivering genetic information, such as RNA molecules, into cells, particularly in targeting diseased cells for treatment or identifying aberrant cells, due to inefficiencies in delivery and specificity.

Innovation Solution

Development of compositions that include compacted RNA molecules attached to nucleic acid nanoparticles, utilizing linkers and packing components to enhance stability, specificity, and intracellular targeting, allowing for controlled expression and endosomal escape, thereby improving the delivery of genetic information into specific cell types.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If RNA molecules are delivered using conventional methods, then delivery efficiency is low, but the complexity of the delivery system remains simple

Engineering Contradiction:
Improvedelivery efficiencyVSAvoiddelivery system complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent employs composite nanoparticle structures composed of multiple functional components including RNA molecules, protective coatings, and targeting ligands. These composite nanoparticles integrate multiple functions (protection, delivery, targeting) into a single delivery system, thereby improving delivery efficiency while managing complexity through functional integration rather than separate delivery mechanisms

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The delivery system is segmented into distinct functional modules: the RNA cargo, the nanoparticle carrier, protective elements, and targeting components. This modular segmentation allows each component to be optimized independently for its specific function while maintaining overall system efficiency, resolving the contradiction between improved delivery and system complexity

Inventive Principle:
Principle #1Segmentation

2Manufacturing precision

If conventional delivery methods are used, then cell specificity is poor, but the cost of the delivery system remains low

Engineering Contradiction:
Improvecell specificityVSAvoiddelivery system complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The nanoparticle surface is modified with specific targeting ligands at localized positions to recognize and bind to receptors uniquely expressed on target cells. This local quality enhancement (adding specificity at the interaction interface) improves cell targeting precision without requiring complete redesign of the entire delivery system, thus managing complexity while achieving high specificity

Inventive Principle:
Principle #3Local quality

3Stability of the object's composition

If RNA molecules are delivered without compaction, then stability during transport is low, but the manufacturing process remains simple

Engineering Contradiction:
ImproveRNA stabilityVSAvoidmanufacturing simplicity
Core Design Contradiction:
Stability of the object's compositionVSEase of manufacture

Solution Approach 1:

The RNA molecules are nested within the nanoparticle structure, which provides physical protection and a stable environment during transport. This nesting approach encapsulates the fragile RNA cargo within a protective carrier, enhancing stability during circulation and delivery while maintaining relatively simple manufacturing processes through self-assembly or straightforward encapsulation techniques

Inventive Principle:
Principle #7Nested doll (Nesting)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

These compositions achieve superior transfer of genetic information, reducing off-target effects and enhancing therapeutic efficacy in treating genetically-driven diseases while enabling early detection of genetic disorders.

Implementation Method 1

The element may promote internalization of the cargo molecule into a cell in the subject

Methodology Applied
Scientific EffectEndocytosis:

Implementation Method 2

the element may promote escape of the cargo molecule from an endosome within a cell of the subject

Methodology Applied
Scientific EffectEndosomal escape:

Data Source

PatentUS20230183746A1Compositions for transfer of cargo to cells
Publication Date: 2023.06.15 SIXFOLD BIOSCI LTD
  • US20230183746A1 patent drawing
  • US20230183746A1 patent drawing
  • US20230183746A1 patent drawing

AI summary

The invention provides compositions containing cargo molecules attached to elements that improve the function of the cargo molecules in the body of a subject. The compositions are useful for therapeutic and diagnostic purposes.